Creative Medical Technology Holdings, Inc. CELZ

1.03 0.06 6.19% as of 25 Sep
Market cap
$6.4M
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.30 0.00 0.00 0.00 0.00 —
P/S ratio
274.72 170.99 78.39 26.00 54.67 48.92 1,406.15 23,313.55 0.00 —
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
P/Operating CF
(2.41) (1.75) (3.42) (1.13) (4.96) 141.44 (922.02) (9,807.93) (779,882.64) —
P/B ratio
0.62 0.54 0.63 0.26 0.56 0.00 0.00 0.00 0.00 —
EV/Sales
12.15 11.18 (9.30) (9.65) (21.11) 53.13 1,412.04 23,316.59 0.00 —
EV/EBITDA
0.00 0.00 0.14 0.15 0.00 0.00 376.74 17,547.39 0.00 —
EV/FCF
(0.02) (0.02) 0.06 0.11 0.86 (11.00) (192.64) (2,756.42) (107,567.26) —
Current Ratio
25.97 18.73 27.65 5.64 10.22 0.00 0.01 0.07 0.01 0.49
Net Debt/EBITDA
1.20 1.05 1.81 0.82 (9.54) (10.14) 1.57 2.29 (0.28) 0.13
Debt/Equity
0.00 0.00 0.00 0.00 0.00 (0.02) (0.13) (0.17) (0.11) (0.81)
ROE
(86.53%) (65.85%) (40.34%) (77.78%) (129.86%) 151.73% 140.55% 438.12% 222.15% 1,414.77%
ROA
(82.81%) (63.20%) (35.36%) (66.62%) 320.57% (5,818.55%) (1,683.27%) (4,014.61%) (1,011.83%) (411.77%)
ROIC
(1,213.03%) (895.02%) (984.74%) (84.87%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(84.27%) (94.59%) (53.40%) (65.76%) 198.33% 89.86% 99.71% 328.41% 110.03% 330.22%
Average Days of Receivables
0.00 0.00 0.00 0.00 10.39 0.00 12.35 28.17 365.00 —
Earnings Yield
(132.14%) (160.61%) (80.65%) (262.78%) 333.71% (451.35%) (3.65%) (0.47%) 0.00% —
Free Cash Flow Yield
(239.34%) (310.63%) (208.48%) (323.81%) (44.74%) (9.87%) (0.52%) (0.04%) 0.00% —
Free Cash Flow per Share
(2.46) (3.72) (5.77) (7.13) (8.51) (11.82) (1.17) (2.69) (0.08) (0.05)
Book value per Share
3.16 4.28 7.35 14.51 39.22 (687.44) (7.80) (10.23) (0.21) (0.02)
Free Cash Flow
(5.86) (5.50) (8.13) (7.80) (2.22) (0.68) (1.21) (1.05) (0.89) (0.46)
EV/EBIT
0.00 0.00 0.14 0.15 0.71 0.00 0.00 0.00 0.00 —
Other line items

Show all line items

Columns are period end dates